Asian ADRs Barely Higher Monday Morning; Quidan, Aslan Pharma Surge

Last Updated: Monday, June 14, 2021 10:47 AM | MT Newswires

American depositary receipts of Asian stocks were trading not quite 0.1% higher at 2,148.81 on the S&P/BNY Mellon Asia 50 ADR Index Monday morning.

North Asia winners were led by micro-lender Qudian (QD), which climbed 11%, and blockchain developer Xunlei (XNET), which rose 9.3%. They were followed by fintech platform FinVolution Group (FINV) and semiconductors designer Himax (HIMX), which gained 8.6% and 8.4% respectively.

The biggest decliners from North Asia were wealth manager Jupai (JP) and casino and resort operator Melco (MLCO), which fell 3.5% and 3% respectively. They were followed by Shinhan Financial Group (SHG), down 2.6%, and RYB Education (RYB), which dropped 2.2%.

In South Asia, the gainers were led by biotech Aslan Pharmaceuticals (ASLN), which climbed 15%. ASLAN was followed by digital entertainment platform Sea (SE), automaker Tata Motors (TTM), and generic drugs maker Dr. Reddy's Laboratories (RDY), all with gains below 1%.

Among decliners from South Asia, telecom operators Telekomunikasi Indonesia (TLK) and PLDT (PHI) lost 1.7% each. IT contractor Sify (SIFY) and miner Vedanta (VEDL), were down 1.6% and 1.5% respectively.

Share this article:

You May Also Like